- On Announcement of All Oral MDR TB regimen by Indian Government
- Modi visit to US: Trump appearance signals importance of India
- After ‘Howdy Modi’, Trump and Modi likely to sign trade deal
- US – India Relations: President Trump To Sign New Trade Deal With Indian PM Modi?
- India-US trade talks: Trading lives?
Category Archives: Protest&Campaigns
Source: Keionline 21st May, 2019 24 May 2019- KEI panel discussion- Assessing the implications of the development of new cell and gene-based therapies (including CART and CRISPR): What role should WHO play? On Friday, 24 May 2019, Knowledge Ecology International … Continue reading
12th Nov 2018, New Delhi The RCEP ministerial meeting is taking place today, 12th November, 2018 in Singapore. It will be followed by Leaders’ Summit on 14th November. There are clear indications that countries want to wrap up the negotiations that started in … Continue reading
Source: Bloomberg | November 1, 2018 The U.S. patent system was designed to protect new innovations, but drugmakers are more often than not using it to protect old ones. At least 74 percent of drugs associated with new patents were medicines … Continue reading
Source: Fix the Patent Laws Intellectual property policy welcomed after nine years of development JOHANNESBURG, 31 MAY 2018 – Yesterday, after nine years of development, the Department of Trade and Industry (the dti) finally published the Intellectual Property Policy of the … Continue reading
Source: The Wire | May 27, 2018 New Delhi: Tragedies can be tipping points for change. And through their bereavements, four families have come together to demand accountability and change from the government as well as from private hospitals. They are … Continue reading
Source: Fix the Patent Laws | May 24, 2018 The Fix the Patent Laws Coalition (FTPL) welcomes the news today that the Cabinet of the Government of South Africa has approved the new Intellectual Property (IP) Policy. After nine years of … Continue reading
Report on Pharmaceutical Patents in India – How our safeguards against evergreening have failed, and why the system must be reformed
The recent report on “Pharmaceutical Patent Grants in India How our safeguards against evergreening have failed, and why the system must be reformed” shows immense irregularities in grant of patents in the country. Over the past decades India’s patent system has … Continue reading